The MMP9 gene metaphyseal anadysplasia type 2 genetic test is a specialized diagnostic tool used to identify mutations in the MMP9 gene, which are linked to metaphyseal anadysplasia type 2, a rare genetic disorder. This condition is characterized by skeletal abnormalities including short stature, bowed legs, and other bone growth irregularities. The test is crucial for accurate diagnosis, enabling targeted treatment and management plans for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves analyzing the patient's DNA to look for specific mutations in the MMP9 gene that are known to cause the disorder. The process is comprehensive, ensuring a high degree of accuracy in the results.
The cost of the MMP9 gene metaphyseal anadysplasia type 2 genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to conduct the test. Patients seeking this test can expect professional service and reliable results, providing crucial information for managing the condition effectively.
The PCNT Gene Microcephalic Osteodysplastic Primordial Dwarfism Type 2 (MOPD II) Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PCNT gene, which are associated with MOPD II. This condition is characterized by extremely small stature, skeletal abnormalities, and microcephaly, where individuals have a significantly smaller head size compared to others of the same age and sex. Early detection through this genetic test can aid in the management and understanding of the condition, allowing for tailored care and support.
Priced at 4400 AED, the test involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the PCNT gene. The results from this test can provide crucial information for families and healthcare providers, including the confirmation of a MOPD II diagnosis, insight into the potential severity of the condition, and guidance for future family planning.
DNA Labs UAE is equipped with advanced genetic testing technology and staffed by professionals experienced in genetic diagnostics, ensuring accurate and reliable results. This test represents an important step for affected individuals and their families in understanding their condition and making informed decisions about their health and care plans.
The TUBGCP6 gene plays a crucial role in cellular processes, particularly in cell division and the proper development of the brain and eyes. Mutations in the TUBGCP6 gene can lead to a rare genetic disorder known as Microcephaly and Chorioretinopathy, which may also be accompanied by mental retardation. This condition is characterized by a significantly smaller head size (microcephaly) and abnormalities in the retina (chorioretinopathy), potentially affecting vision. Mental retardation, although not always present, can be an additional complication, impacting cognitive development and function.
To diagnose this condition and identify the specific genetic mutation, a genetic test targeting the TUBGCP6 gene can be performed. This test is crucial for families seeking answers about this rare condition, as it can confirm the diagnosis, inform treatment decisions, and provide insights into the risk of recurrence in future pregnancies.
In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the test is set at 4400 AED, reflecting the advanced technology and expertise required to accurately identify mutations in the TUBGCP6 gene. Conducting this test at DNA Labs UAE ensures that individuals and families receive reliable results, supported by a team of professionals specialized in genetic diagnostics. This service is particularly valuable for those affected by or at risk of this rare genetic condition, providing essential information for managing health and making informed decisions about care and support.
The "WDR62 Gene Microcephaly with Cortical Malformations Autosomal Recessive Type 2 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to identify mutations in the WDR62 gene, which are known to cause Microcephaly with Cortical Malformations, Autosomal Recessive Type 2 (MCCM2). MCCM2 is a genetic disorder characterized by significantly reduced head size (microcephaly) and abnormalities in the cerebral cortex's development, leading to various neurological impairments.
The test involves analyzing the patient's DNA to detect any alterations in the WDR62 gene that may be responsible for the condition. Early detection through this genetic testing is crucial for the management and treatment of the disorder, allowing for a better understanding of the prognosis and the possibility of genetic counseling for affected families.
DNA Labs UAE offers this comprehensive genetic test at a cost of 4400 AED. The procedure is conducted in their state-of-the-art facilities, ensuring high accuracy and reliability of the results. By opting for this test, individuals at risk of having children with MCCM2 can make informed decisions about their family planning, while affected families can gain insights into the condition, paving the way for supportive therapies and interventions.
The IER3IP1 Gene Microcephaly with Epilepsy and Diabetes Syndrome Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, aimed at identifying mutations in the IER3IP1 gene. These mutations are known to be associated with a rare, inherited disorder characterized by microcephaly (a condition where a baby's head is significantly smaller than expected), epilepsy, and diabetes syndrome. This comprehensive test is crucial for families seeking answers to developmental delays, seizures, and other related symptoms in their children, providing them with vital information for management and treatment plans.
The test, priced at 4400 AED, involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the state-of-the-art facilities at DNA Labs UAE. The laboratory employs advanced genetic sequencing technologies to accurately identify any mutations in the IER3IP1 gene, ensuring reliable results. By opting for this test, families can gain insights into the genetic underpinnings of the condition, enabling healthcare providers to tailor interventions and support to meet the specific needs of the affected individual.
The KIF11 Gene Microcephaly with or without Chorioretinopathy, Lymphedema, or Mental Retardation (MCLMR) Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the KIF11 gene. These mutations are associated with a rare genetic disorder that manifests as a spectrum of symptoms, including microcephaly (a condition where a baby's head is significantly smaller than expected), potential vision problems due to chorioretinopathy, lymphedema (swelling due to lymphatic system blockages), and in some cases, mental retardation. The test, priced at 4400 AED, provides crucial information for the diagnosis and management of this condition, enabling targeted interventions and support for affected individuals and their families.
The GFM2 Gene Microcephaly with Simplified Gyral Pattern and Insulin-Dependent Diabetes Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the GFM2 gene. This gene has been associated with a rare but severe condition characterized by microcephaly (a smaller than normal head size), a simplified gyral pattern of the brain, and insulin-dependent diabetes. These symptoms represent a complex neurodevelopmental disorder that can significantly impact the affected individual's quality of life.
The test involves analyzing the patient's DNA to identify any genetic alterations in the GFM2 gene that could lead to the development of these conditions. It is particularly crucial for early diagnosis and management of the symptoms, especially for guiding treatment options for the insulin-dependent diabetes component of the disorder.
DNA Labs UAE offers this genetic test at a cost of 4400 AED. The laboratory is equipped with state-of-the-art technology to ensure accurate and reliable results. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling informed decisions regarding their health and medical care. This test is especially recommended for individuals with a family history of the condition or those exhibiting symptoms related to the disorder.
The SLC25A19 Gene Microcephaly Amish Type Genetic Test is a specialized diagnostic tool designed to identify mutations in the SLC25A19 gene, which are linked to a rare form of microcephaly primarily found in the Amish population. Microcephaly Amish Type, also known as Amish Microcephaly, is a genetic condition characterized by significantly reduced head size and brain volume, leading to developmental delays and neurological issues. This test is crucial for early detection, allowing for appropriate intervention and support for affected individuals and their families.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, typically through a blood draw or cheek swab. The sample is then analyzed to detect any mutations in the SLC25A19 gene that are indicative of Microcephaly Amish Type. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the sophisticated technology employed.
Early diagnosis through the SLC25A19 Gene Microcephaly Amish Type Genetic Test can significantly impact the management of the condition, offering insights into potential treatments and therapies. It also provides families with valuable information regarding the genetic risks for future pregnancies. DNA Labs UAE ensures confidentiality and accuracy, offering support and guidance throughout the testing process.
The AP4M1 gene is crucial in human development, playing a significant role in the formation and function of the nervous system. Mutations in the AP4M1 gene are associated with a form of microcephaly, a neurological condition characterized by a smaller than normal head size, which often leads to developmental delays and intellectual disabilities. This condition is part of a group of disorders known as AP-4 deficiency syndromes, which can also affect movement and speech.
To diagnose and understand the genetic basis of microcephaly related to the AP4M1 gene, genetic testing is available. This test specifically looks for mutations in the AP4M1 gene that are known to cause the condition. Conducted at DNA Labs UAE, the test offers a comprehensive analysis to identify the genetic alterations in the AP4M1 gene.
The cost of the AP4M1 gene microcephaly-related genetic test at DNA Labs UAE is 4400 AED. This test is a crucial step for families seeking answers about the genetic underpinnings of microcephaly in their loved ones, providing them with essential information for management and treatment options. It's also valuable for planning future pregnancies and understanding the risk of microcephaly in future offspring.
The MCPH1 Gene Microcephaly Autosomal Recessive Type 1 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the MCPH1 gene, which are linked to the development of Microcephaly Autosomal Recessive Type 1. This condition is characterized by significantly reduced head circumference, often accompanied by developmental delays and neurological issues. The test is crucial for families with a history of the condition or those who have children showing symptoms, as early detection can aid in managing and understanding the potential challenges associated with the disorder.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed to detect any abnormalities in the MCPH1 gene. The cost of the test is 4400 AED, an investment that provides invaluable insights into genetic predispositions, enabling informed decisions about care and support for affected individuals and their families. DNA Labs UAE ensures confidentiality and accuracy, providing a comprehensive report that is crucial for medical professionals in devising appropriate treatment and intervention strategies.
